Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 517,008 shares of SLS stock, worth $610,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
517,008
Previous 273,063
89.34%
Holding current value
$610,069
Previous $275,000
123.64%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
4.38MCall Options Held
3.27MPut Options Held
56.3K-
Vanguard Group Inc Valley Forge, PA1.79MShares$2.11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$507,8340.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$363,9893.71% of portfolio
-
Opus Capital Group, LLC226KShares$266,7980.04% of portfolio
-
Equitable Holdings, Inc. New York, NY210KShares$247,8000.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.3M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...